Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.930
-0.010 (-0.52%)
Aug 29, 2025, 4:00 PM - Market closed

Entera Bio Statistics

Total Valuation

Entera Bio has a market cap or net worth of $88.13 million. The enterprise value is $77.48 million.

Market Cap88.13M
Enterprise Value 77.48M

Important Dates

The last earnings date was Friday, August 8, 2025, after market close.

Earnings Date Aug 8, 2025
Ex-Dividend Date n/a

Share Statistics

Entera Bio has 45.66 million shares outstanding. The number of shares has increased by 26.34% in one year.

Current Share Class 45.66M
Shares Outstanding 45.66M
Shares Change (YoY) +26.34%
Shares Change (QoQ) +7.97%
Owned by Insiders (%) 1.97%
Owned by Institutions (%) 8.43%
Float 28.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 530.91
Forward PS n/a
PB Ratio 4.34
P/TBV Ratio 5.11
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 466.72
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.47, with a Debt / Equity ratio of 0.01.

Current Ratio 10.47
Quick Ratio 5.89
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -82.22% and return on invested capital (ROIC) is -50.28%.

Return on Equity (ROE) -82.22%
Return on Assets (ROA) -44.56%
Return on Invested Capital (ROIC) -50.28%
Return on Capital Employed (ROCE) -59.41%
Revenue Per Employee $8,300
Profits Per Employee -$530,100
Employee Count20
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

In the past 12 months, Entera Bio has paid $14,000 in taxes.

Income Tax 14,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +16.76% in the last 52 weeks. The beta is 1.52, so Entera Bio's price volatility has been higher than the market average.

Beta (5Y) 1.52
52-Week Price Change +16.76%
50-Day Moving Average 1.93
200-Day Moving Average 2.01
Relative Strength Index (RSI) 48.66
Average Volume (20 Days) 64,750

Short Selling Information

Short Interest 37,177
Short Previous Month 55,477
Short % of Shares Out 0.08%
Short % of Float 0.13%
Short Ratio (days to cover) 0.15

Income Statement

In the last 12 months, Entera Bio had revenue of $166,000 and -$10.60 million in losses. Loss per share was -$0.25.

Revenue166,000
Gross Profit n/a
Operating Income -10.59M
Pretax Income -8.51M
Net Income -10.60M
EBITDA -10.55M
EBIT -10.59M
Loss Per Share -$0.25
Full Income Statement

Balance Sheet

The company has $10.86 million in cash and $203,000 in debt, giving a net cash position of $10.66 million or $0.23 per share.

Cash & Cash Equivalents 10.86M
Total Debt 203,000
Net Cash 10.66M
Net Cash Per Share $0.23
Equity (Book Value) 17.26M
Book Value Per Share 0.44
Working Capital 17.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.66 million and capital expenditures -$40,000, giving a free cash flow of -$6.70 million.

Operating Cash Flow -6.66M
Capital Expenditures -40,000
Free Cash Flow -6.70M
FCF Per Share -$0.15
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -6,378.92%
Pretax Margin -6,378.31%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -26.34%
Shareholder Yield -26.34%
Earnings Yield -12.03%
FCF Yield -7.60%

Analyst Forecast

The average price target for Entera Bio is $10.00, which is 418.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 418.14%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Entera Bio has an Altman Z-Score of 9.77 and a Piotroski F-Score of 3.

Altman Z-Score 9.77
Piotroski F-Score 3